Echo Street Capital Management LLC Eli Lilly & CO Transaction History

Echo Street Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $456,610 - $590,622	-2,529 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $415,565 - $537,968	2,529 New	2,529 $472,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $198,712 - $229,847	-1,359 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $185,394 - $223,120	1,359 New	1,359 $223,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.